From
StayCurrentMD
Journal of Pediatric Article Review: June 2023, AAP Issue
With Dr. Colin Martin & Dr. Brad Warner & Dr. Andrew Fleming · hosted by Dr. Cecilia Gigena & Dr. Em Gootee & Dr. Todd Ponsky
Chapter 1 of 5 · Evidence & Research
Introduction
Introduction and Episode Overview
Expert statements on this page
No expert statements were drawn from this page.
Host summaries · secondary, not cited in answers
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Video
Transition of Care - Alcohol and Smoking
4 min · Published Nov 2023
Video
ERNICA Research Collaboration Webinar on Quality of Life
61 min · Published Nov 2023
Video
Outcomes of Children With Short Bowel Syndrome: Experiences in a Multidisciplinary Intestinal Rehabilitation Unit Over Two Decades
45 s · Published Mar 2025
Video
Impact of social determinants of health on outcomes in pediatric short bowel syndrome...
43 s · Published Aug 2026
Video
Disruption of enterohepatic Circulation of Bile acids ameliorates small bowel resection associated hepatic injury
59 s · Published Aug 2023
Podcast
Intestinal Rehabilitation Episode 8: Refeeding of an Older Patient
12 min · Published Oct 2023
Video
Clinical & Research Update: Pediatric Liver Tumors - A Case-Based Discussion with Drs. Katherine Somers & Alex Bondoc
69 min · Published Apr 2026
Video
Characteristics of Transfusion and Association With Oncologic Outcomes in Hepatoblastoma Resection
1 min · Published Apr 2026
Video
Pediatric Obesity Is a Disease: Treatment, Medications, Surgery & Equity in Care with Dr. Justin Ryder
Lurie Children's Hospital · 6 min · Published Mar 2026
Video
Quality of Life Outcomes for Patients Who Underwent Conventional Resection and Liver Transplantation for Locally Advanced Hepatoblastoma
1 min · Published Jan 2026
Video
Indocyanine green is a sensitive adjunct in the identification and surgical management of local and metastatic hepatoblastoma
1 min · Published Jan 2026
Video
Retreatment with Cisplatin May Provide a Survival Advantage for Children with Relapsed/Refractory Hepatoblastoma: An Institutional Experience
1 min · Published Jan 2026
Video
Pediatric Surgical Oncology Research Collaborative (PSORC): Studying Rare Pediatric Tumors
56 s · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Pooling Patients to Study Rare Pediatric Tumors: An Introduction to PSORC
56 s · Published May 2026
Video
The fetal frontier: A review of current and emerging fetal therapies for genetic diseases
44 s · Published May 2026
Video
Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients
1 min · Published May 2026
Video
Tricuspid valve surgery in transposition of the great arteries with a systemic right ventricle
46 s · Published May 2026
What the experts said
The ileocecal region may not be important to preserve in short bowel syndrome and may actually be injurious
Administration of a specific bile acid that is more lipophilic and hepatoprotective could be potential therapy for patients with cholestatic liver disease after massive intestinal resection
In clinical practice, surgeons cannot choose which intestinal segment to remove - they must remove what is dead and preserve as much viable bowel as possible
Once NED status was achieved, 10-year overall survival among high-risk hepatoblastoma patients was similar to patients who were not high-risk
There is no threshold for disease burden that precludes aggressive pursuit of no-evidence-of-disease status in children with hepatoblastoma
Having a formal aerodigestive team is the way to ensure esophageal atresia surveillance gets done
Proximal small bowel resection results in greater oxidative stress in the liver, evidenced by elevated mRNA transcripts for tumor necrosis factor alpha, NADPH oxidase, and glutathione synthase with greater compensatory antioxidant response
46 of 50 hepatoblastoma patients underwent resection using adjuvant techniques including total hepatic vascular exclusion, vascular reconstruction, biliary reconstruction, or en-bloc resection and total hepatectomy with transplantation
82% (41 of 50) of hepatoblastoma patients were able to achieve no-evidence-of-disease (NED) status
14 high-risk hepatoblastoma patients underwent a median of 2.5 pulmonary metastasectomies (7 for unilateral disease, 7 for bilateral disease) with a median of 4.5 nodules resected
5 high-risk hepatoblastoma patients relapsed and 3 of them were saved; NED status was inversely correlated with 5-year mortality
The esophageal atresia surveillance survey had a 77% response rate from 181 physicians at 19 institutions
Only 36% of institutions perform routine upper GI endoscopy in esophageal atresia patients regardless of symptoms, despite evidence showing these patients should be surveilled
Without proper surveillance, esophageal atresia patients could be at risk for esophageal cancer and chronic dysmotility as they survive into adulthood